By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

XTL Biopharmaceuticals Ltd. 

Kiryat Weizmann, Science Park, Bldg 3
P.O. Box 370
Rehovot    76100  Israel
Phone: 972-8-932-4444 Fax: 972-8-930-4445


SEARCH JOBS








Company News
XTL Biopharma (XTLB) Unveils Expanded hCDR1 Preclinical Data For The Treatment Of Sjögren’s Syndrome 4/5/2017 8:50:28 AM
XTL Biopharma (XTLB) Reports 2016 Financial Results & Provides Clinical And Operational Update 3/30/2017 9:57:05 AM
XTL Biopharma (XTLB) Announces Closing of $2.8 Million Private Placement From Existing Investors 3/22/2017 8:49:44 AM
XTL Biopharma (XTLB) Announces $2.8 Million Private Placement From Existing Investors 3/8/2017 11:08:38 AM
XTL Biopharma (XTLB) Regains Compliance With Nasdaq Minimum Bid Price Listing Requirement 3/1/2017 11:19:08 AM
XTL Biopharma (XTLB) Announces $2.5 Million Registered Direct Offering 2/17/2017 6:32:21 AM
XTL Biopharma (XTLB) Expands Clinical Advisory Board To Support Phase II Study Of HCDR1 In Sjogren's Syndrome 2/13/2017 8:41:06 AM
XTL Biopharma (XTLB) Announces Ratio Change Of Its Depositary Receipt Program 1/27/2017 7:42:59 AM
XTL Biopharma (XTLB)' Preclinical Studies of hCDR1 Demonstrate Therapeutic Potental In the Treatment of Sjögren's Syndrome 1/5/2017 6:49:12 AM
XTL Biopharma (XTLB) Reports Third Quarter 2016 Financial Results & Provides Clinical And Operational Update 12/6/2016 11:27:41 AM
12345678910...
//-->